Pharmacologic profile of a low-molecular-weight heparin depolymerized by gamma-irradiation.
Low molecular weight heparins (LMWHs) are considered to be the agent of choice for the prophylaxis of DVT in medical and surgical patients. Conventionally, these agents have been produced by fractionation of or by chemical or enzymatic depolymerization of native heparin. The fractionated heparin retains many of its biological properties such as AT III affinity and sulfate content gamma-irradiation (60Co) has been used to depolymerize GAGs (De Ambrosi et al. In: biomedical and Biotechnological Advances in Industrial Polysaccharides, pp. 45-53). This procedures has now been used for the preparation of LMWH derivatives of varying molecular weight. The current studies examine the biochemical and pharmacologic profile of one such gamma-irradiated depolymerized heparin. In standard clotting and amidolytic antiprotease assays (PT, APTT, AXa, Alla), gamma-irradiated depolymerized heparin produced equal or stronger activity when compared to a LMWH produced by nitrous acid depolymerization and retained the ability to active AT III and HCHII. Initial results indicate that LMWHs produced by gamma-irradiation exhibit comparable antithrombotic actions to those produced by chemical depolymerization when measured in animal models of thrombosis. gamma-Irradiation may be a useful method for the production of LMWHs.
Jeske
W
W
Department of Pathology, Loyola, Univ. Med. Center, Maywood, IL 60153, USA.
Iqbal
O
O
Gonnela
S
S
Boveri
G
G
Torri
G
G
De Ambrosi
L
L
Fareed
J
J
D000818:Animals; D003037:Cobalt Radioisotopes; D004195:Disease Models, Animal; D005720:Gamma Rays; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology* / Q000528:radiation effects; D009608:Nitrous Acid; D011108:Polymers; D011817:Rabbits; D013927:Thrombosis / Q000188:drug therapy*
D003037:Cobalt Radioisotopes; D006495:Heparin, Low-Molecular-Weight; D011108:Polymers; D009608:Nitrous Acid